NCT04673942
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04673942
Title A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors (BETA-PRIME)
Acronym BETA-PRIME
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
California Cancer Associates for Research and Excellence, cCARE San Marcos California 92069 United States Details
Providence Saint John's Health Center Santa Monica California 90404 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field